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Summary TSPO mediated transport of cholesterol into the mitochondrion is a necessary step in
steroid synthesis. The rs6971 polymorphism in the TSPO gene causes an amino acid substitution
(Ala147Thr) within the transmembrane domain where the cholesterol-binding pocket is located,
and has been shown to affect the steroidogenic pathway. We report a nominal association
between this TSPO polymorphism and the diagnosis of Bipolar Disorder in both the genome-wide
dataset of the Wellcome Trust Case—Control Consortium and the Psychiatric Genome-Wide
Association Study Consortium Bipolar Disorder group (OR = 1.11, p = 0.007; OR = 1.10,
p = 0.011, respectively). We propose that the amino acid substitution affects hypothalamic—
pituitary—adrenal (HPA) regulation, and hence may predispose to Bipolar Disorder. This supports
the hypothesis that HPA dysregulation has a causal role in Bipolar Disorder, and is not just a
consequence of the disease.
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Bipolar Disorder is associated with a Translocator Protein gene polymorphism 28271. Introduction
The aetiopathogenesis of Bipolar Disorder (BD) involves both
environmental and genetic factors. The hypothalamic—pitui-
tary—adrenal (HPA) axis is a physiological system which is
subject to both these influences and is dysregulated in BD
both during acute illness and as an enduring correlate (Wat-
son et al., 2004). Furthermore, increased daytime cortisol
secretion, which reflects HPA axis dysfunction, has been also
observed in the adolescent offspring of parents with BD and
persists into young adulthood (Ellenbogen et al., 2006).
However, it is currently unclear whether the HPA axis dys-
function is a cause or consequence of BD.
The rate-limiting step in the synthesis of all steroids,
including those involved in the HPA axis, is the delivery of
cholesterol from the outer (OMM) to the inner mitochondrial
membrane (IMM). At the IMM, cholesterol is converted to
pregnenolone, the common precursor for all steroids, by the
cytochrome P450 enzyme CYP11A1, which cleaves the cho-
lesterol side chain. The delivery of cholesterol to the IMM is
dependent upon the function of the 18 kDa Translocator
Protein (TSPO), located on the OMM, which binds cholesterol
with high affinity and imports it across the membrane. If
TSPO is knocked down or pharmacologically inhibited, steroid
synthesis ceases (Hauet et al., 2005). A common single
nucleotide polymorphism (rs6971) in the TSPO gene leads
to an amino-acid substitution, Ala147Thr, which dramatically
alters the affinity with which TSPO binds drug ligands (Owen
et al., 2012). As cholesterol also binds TSPO in the same
transmembrane domain, we hypothesised that this substitu-
tion may impair the ability of TSPO to bind or import cho-
lesterol, and hence may affect steroid synthesis and HPA
function.
The hypothesis that HPA dysfunction plays a causal role in
BD pathophysiology would be supported by a finding that a
genetic variant, which leads to a dysregulated HPA function,
is associated with diagnosis of BD. To test this we investigated
the association between rs6971 and a diagnosis of BD in the
datasets of the Wellcome Trust Case—Control Consortium
(WTCCC) and the Psychiatric Genome-Wide Association Study
Consortium Bipolar Disorder group (PGC-BD).
2. Materials and methods
This is a large-scale case—control study which aims to test the
association between the SNP: rs6971 and BD. We analysed the
cases reported in the BD subset of the WTCCC genome-wide
association study (GWAS), which comprises 1868 BD cases and
2938 controls (WTCCC, 2007). The study procedures were
conducted in accordance with the Declaration of Helsinki and
were carried out after all subjects provided informed written
consent.
As rs6971 was not directly genotyped in the WTCCC study,
the data were imputed from nearby SNPs using the software
IMPUTE2 according to the method of Howie et al. (2009). The
SNP rs138911, in linkage disequilibrium with the SNP of
interest, rs6971, was genotyped to further infer the allele
of the SNP rs6971.
The analysis of the association between rs6971 and diag-
nosis of BD was also examined using the meta-analytic data of
the PCG-BD, which combines primary genotype data fromlarge GWAS datasets. The PGC-BD dataset is made up of 7481
cases and 9250 controls, and also comprises the WTCCC data
(Sklar et al., 2011). For the PCG-BD, rs6971 was imputed
using the software BEAGLE (Browning and Browning, 2007).
3. Results
In this imputation-based analysis of the WTCCC sample we
observed an underrepresentation of the minor allele (Thr147)
of the SNP rs6971 in BD, with a frequency of 31.1% in BD and
33.4% in controls (OR 1.1148; p = 0.007). The frequencies of
genotypes of the SNP rs138911, in linkage disequilibrium with
rs6971 (LD R2 = 0.77), in BD patients were T/T: 6.3%; T/G:
40%; G/G: 53.6%; whilst the frequencies of genotypes in
controls were T/T: 8%; T/G: 41.3%; G/G: 50.7% (Table 1).
The replication analysis from the PGC-BD data showed a
similar association between the SNP rs6971 and BD diagnosis
(Table 1).
4. Discussion
Our data indicate a nominal association between the rs6971
SNP in the TSPO gene and the diagnosis of BD. Evidence for
this is provided by the imputed association in the WTCCC data
between rs6971 and BD diagnosis, as well as by the associa-
tion between BD and the directly genotyped rs138911 SNP, in
linkage disequilibrium with rs6971. The observation of the
association between rs6971 and BD diagnosis was replicated
in the larger, partially overlapping, PGC-BD cohort.
These findings did not reach genome-wise significance in
either sample, and although they provide suggestive evi-
dence for an association of rs6971 with BD, a replication
of these observations is required. It is important to note,
however, that we tested a single specific hypothesis and pre-
specified both phenotype and SNP a priori, making compar-
isons with statistical approaches for GWAS studies difficult.
We hypothesised that rs6971 would be associated with HPA
dysregulation. Hence, we tested for an association with BD,
the psychopathological condition where HPA dysfunction is
most evident and is independent of transient disease state
(Watson et al., 2004). Whilst depression, schizophrenia, and
Post Traumatic Stress Disorder (PTSD) have also been asso-
ciated with HPA alterations, dysfunction in depression is
dependent on disease state, in schizophrenia is much less
marked relative to BD (Sharma et al., 1988), and in PTSD may
represent a marker of exposure to trauma rather than a
specific mechanism of vulnerability for PTSD (Morris et al.,
2012). Hence association with these phenotypes was not
tested.
This hypothesis was based on our in vitro data. Binding of
TSPO to synthetic and endogenous ligands is modulated by
polymer formation (Delavoie et al., 2003), interaction with a
multimeric complex, redistribution of TSPO molecules (Bouj-
rad et al., 1996), and other factors. However, we have shown
that in human samples the predominant determinant of TSPO
binding affinity is the rs6971 polymorphism, although this has
only been tested in synthetic ligands hitherto (Owen et al.,
2012). The amino acid residue which is altered by rs6971
(residue 147) sits within the 5th transmembrane domain of
the TSPO, which is the same location as the cholesterol
binding pocket (Li and Papadopoulos, 1998). As the binding
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2828 A. Colasanti et al.affinity of all synthetic ligands known to bind in the 5th
transmembrane domain is affected by rs6971, we hypothe-
sised that this substitution may alter cholesterol handling by
TSPO. The results we present here are consistent with this
hypothesis.
Although we chose to test for an association with BD on the
basis that rs6971 might impact on HPA dysregulation, it is also
possible that the link between rs6971 SNP and BD is inde-
pendent of the HPA axis and instead mediated by differences
in neurosteroids. Whilst synthesis and control of neuroster-
oids differs from peripheral steroids, the rate-limiting step in
both is TSPO-mediated movement of cholesterol across the
OMM. Hence, an altered cholesterol transport regulation may
potentially affect the biosynthesis of neurosteroids, which
have been directly implicated in the pathophysiology of BD
(Carta et al., 2012). Interestingly, an association between
rs6971 and alteration in peripheral pregnenolone production
has been reported (Costa et al., 2009a). In healthy volun-
teers, the heterozygous and Thr147 homozygous genotype
show significantly lower pregnenolone levels compared with
the Ala147 homozygous, indicating a dominant effect of the
Thr147 allelic variant. This suggests that the presence of at
least one copy of the Thr147 allele may impair cholesterol
translocation efficacy and peripheral steroid production.
However, the downstream effect this has on cortisol produc-
tion, HPA function, or neuroactive steroids’ function, is
unknown.
It should be noted that a study in a Japanese sample (n.
cases = 94; n. controls = 359) found no association of rs6971
with BD (Kurumaji et al., 2001). However, whilst the minor
allele frequency is 30% in Europeans, it is only 4% in the
Japanese population. Hence, this study included no Thr/Thr
subjects and only 17 heterozygotes and so had limited power
to detect any association. Another study in a Caucasian
sample (Costa et al., 2009b) found that rs6971 SNP was
associated to the presence of separation anxiety but not
to a diagnosis of depression (n. unipolar or bipolar depressed
patients: 190; n. controls = 182). The discrepancy between
these and our findings may depend on the different size of the
sample and on the different disease target, possibly suggest-
ing that the association is specific for BD. Another possibility
is that an association of rs6971 with the intermediate phe-
notype ‘separation anxiety’ may underline the observed
association with BD in our sample. We cannot test this in
our study however evidence of high prevalence of separation
anxiety in BD seems to support this hypothesis (Sala et al.,
2010).
There is growing interest in the role of TSPO in the
pathophysiology of anxiety/affective disorders, based on
alterations in neurosteroid concentrations in these diseases
and experimental data showing TSPO targeting drugs might
be efficacious in anxiety disorders (Rupprecht et al., 2010).
Our findings suggest that TSPO may have a causal role in BD
and hence may also be a drug target.
A caveat of our study is that the rs6971 SNP was not
directly genotyped and the association was inferred by
imputation. Although the imputation methods we used to
infer from missing data are well established and supporting
evidence indicates they are accurate (Browning and Brown-
ing, 2007; Howie et al., 2009), the fact that our findings
derived from statistical inference is a disadvantage.
Furthermore, the observed association only reached
Bipolar Disorder is associated with a Translocator Protein gene polymorphism 2829nominal significance for genome-wise studies. By using
uncorrected p-values, up to 1% of SNPs in similarly sized
GWAS studies would be expected to show the level of asso-
ciation observed for rs6971. However, as we tested a unique
specific a priori hypothesis, we feel that the observed asso-
ciation is a meaningful and important finding. Finally the two
datasets, WTCCC and PGC-BD are partially overlapping, as
the WTCCC dataset comprises 25% of the PGC-BD cases.
Although it is possible the association observed in the
PGC-BD dataset is highly influenced by the WTCCC cases,
we observed that the strength of the association of rs6971
SNP to BD diagnosis is similar between the two samples
(OR = 1.11 and 1.10, respectively), despite only 25% overlap
between cases. This suggests that the association in the PCG-
BD cases exists independently of the WTCCC cases. Based on
the above-described limitations, a replication of the study of
this association in an independent sample is warranted to
corroborate our findings.
In conclusion, our findings suggest an association between
BD and the rs6971 polymorphism in the TSPO gene, which may
alter steroid synthesis or its regulation. If this will be con-
firmed by replication, it would provide the first direct evi-
dence that HPA dysregulation may have a causal role in BD
and is not simply a consequence of the disease.
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